Earlier OST Involvement In Device Lifecycle Is Potential User Fee Impact
This article was originally published in The Gray Sheet
Executive Summary
Medical device user fees could spur the Office of Science & Technology to become involved with reviews earlier in the device lifecycle, CDRH topsiders suggest